The KLOW 80mg vial contains KPV 10mg (Lys-Pro-Val, the C-terminal tripeptide of alpha-melanocyte-stimulating hormone at residues 11 to 13, 342.4 g/mol, CAS 64790-08-5), BPC-157 10mg (pentadecapeptide GEPPPGKPADDAGLV, 1419.53 g/mol, CAS 137525-51-0), TB-500 10mg (synthetic thymosin beta 4, 43 residues, 4963.4 g/mol, CAS 77591-33-4) and GHK-Cu 50mg (glycyl-L-histidyl-L-lysine copper(II) complex, 403.9 g/mol, CAS 89030-95-5), co-lyophilised in one container
youll probably be required to participate in weight-management programs in order to maintain your coverage
Expired peptide medications can lose efficacy and may trigger unexpected immune responses
Expansion of clinical evidence supporting cardiovascular benefits and efficacy is fueling treatment uptake
I think there are so many interplays in the brain that are involved with the dopamine pleasure response, and addiction falls into that. A Phase II study published in JAMA Psychiatry in February 2025 seems to bear this potential mechanism out